Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARCE
1801
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $2.2M | ﹤0.01% |
+159,900
| New | +$2.11M |
|
|
FM
1802
DELISTED
iShares Frontier and Select EM ETF
FM
| $2.2M | ﹤0.01% |
85,000
+8,200
| +11% | +$221K |
|
1803
Viemed Healthcare
VMD
$374M
| $2.2M | ﹤0.01% |
326,700
+82,400
| +34% | +$675K |
|
|
ALE
1804
DELISTED
Allete
ALE
| $2.2M | ﹤0.01% |
41,599
+3,000
| +8% | +$169K |
|
1805
Winnebago Industries
WGO
$904M
| $2.19M | ﹤0.01% |
+36,900
| New | +$2.39M |
|
1806
MarineMax
HZO
$796M
| $2.19M | ﹤0.01% |
+66,714
| New | +$2.32M |
|
1807
Southern First Bancshares
SFST
$608M
| $2.19M | ﹤0.01% |
81,207
+1,200
| +1% | +$33.3K |
|
1808
Atlas Energy Solutions
AESI
$1.33B
| $2.19M | ﹤0.01% |
98,400
+7,700
| +8% | +$161K |
|
|
USAP
1809
DELISTED
Universal Stainless & Alloy
USAP
| $2.19M | ﹤0.01% |
166,758
+30,658
| +23% | +$431K |
|
|
PNT
1810
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $2.18M | ﹤0.01% |
327,271
+136,296
| +71% | +$1.13M |
|
1811
Victory Capital Holdings
VCTR
$6.25B
| $2.18M | ﹤0.01% |
65,400
+22,200
| +51% | +$741K |
|
1812
Universal Insurance Holdings
UVE
$1.23B
| $2.18M | ﹤0.01% |
155,200
+131,312
| +550% | +$1.84M |
|
1813
Organogenesis Holdings
ORGO
$305M
| $2.17M | ﹤0.01% |
684,094
-22,008
| -3% | -$69.9K |
|
1814
Assured Guaranty
AGO
$3.66B
| $2.17M | ﹤0.01% |
35,900
-89,600
| -71% | -$5.32M |
|
1815
State Street SPDR S&P Regional Banking ETF
KRE
$4.71B
| $2.17M | ﹤0.01% |
+52,000
| New | +$2.32M |
|
1816
Mirum Pharmaceuticals
MIRM
$6.45B
| $2.17M | ﹤0.01% |
68,700
+57,100
| +492% | +$1.56M |
|
|
FIRY
1817
Firy Inc
FIRY
$154M
| $2.17M | ﹤0.01% |
424,725
+82,400
| +24% | +$732K |
|
1818
Anterix
ATEX
$1.94B
| $2.16M | ﹤0.01% |
+68,900
| New | +$2.17M |
|
1819
Bowman Consulting
BWMN
$472M
| $2.15M | ﹤0.01% |
76,821
-60,279
| -44% | -$1.84M |
|
1820
CION Investment
CION
$310M
| $2.15M | ﹤0.01% |
203,400
-82,688
| -29% | -$895K |
|
|
MAXN
1821
DELISTED
Maxeon Solar Technologies
MAXN
| $2.15M | ﹤0.01% |
1,852
-1,845
| -50% | -$3.51M |
|
1822
NatWest
NWG
$76.5B
| $2.14M | ﹤0.01% |
366,400
+73,600
| +25% | +$445K |
|
1823
Merit Medical Systems
MMSI
$5.21B
| $2.13M | ﹤0.01% |
30,912
-24,800
| -45% | -$1.78M |
|
1824
Integer Holdings
ITGR
$4.25B
| $2.13M | ﹤0.01% |
+27,200
| New | +$2.3M |
|
1825
Interface
TILE
$2.01B
| $2.13M | ﹤0.01% |
217,200
+23,000
| +12% | +$223K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 713 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 713 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.